Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02009930 · ClinicalTrials.gov registry record

Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service

A clinical trial, sponsored by David Grant U.S. Air Force Medical Center.

Terminated
Registry status
112
Enrollment target

NCT02009930 is a clinical trial that was terminated before completion, run by David Grant U.S. Air Force Medical Center. The registered enrollment target is 112 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02009930 was terminated before completion, sponsored by David Grant U.S. Air Force Medical Center.

TERMINATED
Registry status
112 participants
Enrollment target

Study Summary

Hypothesis: Enlisted military members with 10 or more years of service and at least one cardiovascular risk factor will demonstrate a higher risk of future cardiac events as assessed by coronary artery calcium (CAC) scoring than the risk calculated by the Framingham Risk Score.

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2013-11-05
Est. Completion 2018-07-18

What the Registry Record Tells You About NCT02009930

The ClinicalTrials.gov registry entry for NCT02009930 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David Grant U.S. Air Force Medical Center, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02009930 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02009930 about?

NCT02009930 is a clinical study titled "Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service". Hypothesis: Enlisted military members with 10 or more years of service and at least one cardiovascular risk factor will demonstrate a higher risk of future cardiac events as assessed by coronary artery calcium (CAC) scoring than the risk calculated by the Framingham Risk Score.

What is the current status of trial NCT02009930?

This trial is currently terminated. The enrollment target is 112 participants. The study started on 2013-11-05. Estimated completion is 2018-07-18.

Who is sponsoring clinical trial NCT02009930?

This trial is sponsored by David Grant U.S. Air Force Medical Center, which has 21 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.